Aaron Rollins

Executive

Chief Executive Officer

Insider activity · 24 months1 buy1 saleCumulative net flow

Nov 24 · 0 buys · 1 saleDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 1 buy · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (2 ops.)

€459k

▼ Sales (2 ops.)

€5.1M

Latest filing published 20 May 2025 for Airsculpt Technologies, Inc., €6,791. Read the official filing

Filing timeline

BuySale

Aaron Rollins

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

100%

T+90 mean return

+83.9%

Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Aaron Rollins: trading record in brief

Aaron Rollins, listed as chief executive, appears in our data through filings on Airsculpt Technologies, Inc. shares, published by SEC (Form 4). In total, 11 filings cover trades dated from 2 November 2021 to 19 May 2025.

Market trades split into 2 purchases (€459k) and 2 sales (€5.1M). On balance, insiders were net sellers of €4.6M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 7 share grants. 2025 to date brings 1 purchase and no sales.

The record was last updated on 20 May 2025 with an open-market purchase (€6,791) in Airsculpt Technologies, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.